Latest News about BIVI
Recent news which mentions BIVI
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 29, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 16, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session
July 07, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Monday
June 06, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
June 03, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 02, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 08, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 17, 2022
From Benzinga
32 Stocks Moving In Monday's Mid-Day Session
February 14, 2022
From Benzinga
50 Biggest Movers From Yesterday
January 06, 2022
From Benzinga
55 Biggest Movers From Yesterday
December 22, 2021
From Benzinga
60 Biggest Movers From Yesterday
October 27, 2021
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 06, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.